AU2007256352A1 - Therapeutic combination for painful medical conditions - Google Patents

Therapeutic combination for painful medical conditions Download PDF

Info

Publication number
AU2007256352A1
AU2007256352A1 AU2007256352A AU2007256352A AU2007256352A1 AU 2007256352 A1 AU2007256352 A1 AU 2007256352A1 AU 2007256352 A AU2007256352 A AU 2007256352A AU 2007256352 A AU2007256352 A AU 2007256352A AU 2007256352 A1 AU2007256352 A1 AU 2007256352A1
Authority
AU
Australia
Prior art keywords
pain
combination
agent
lacosamide
lower alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2007256352A
Other languages
English (en)
Inventor
Bettina Beyreuther
Thomas Stohr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB Pharma GmbH
Original Assignee
UCB Pharma GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/506,524 external-priority patent/US20070043120A1/en
Priority claimed from PCT/EP2006/008171 external-priority patent/WO2007020103A2/fr
Priority claimed from US11/506,578 external-priority patent/US20070048372A1/en
Priority claimed from US11/506,577 external-priority patent/US20070042969A1/en
Application filed by UCB Pharma GmbH filed Critical UCB Pharma GmbH
Publication of AU2007256352A1 publication Critical patent/AU2007256352A1/en
Assigned to UCB PHARMA GMBH reassignment UCB PHARMA GMBH Alteration of Name(s) of Applicant(s) under S113 Assignors: SCHWARZ PHARMA AG
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
AU2007256352A 2006-06-08 2007-06-06 Therapeutic combination for painful medical conditions Abandoned AU2007256352A1 (en)

Applications Claiming Priority (15)

Application Number Priority Date Filing Date Title
US81184006P 2006-06-08 2006-06-08
US81185906P 2006-06-08 2006-06-08
US60/811,840 2006-06-08
US60/811,859 2006-06-08
US11/506,524 US20070043120A1 (en) 2005-08-18 2006-08-18 Therapeutic combination for painful medical conditions
US11/506578 2006-08-18
US11/506577 2006-08-18
US11/506524 2006-08-18
AUPCT/EP2006/008171 2006-08-18
PCT/EP2006/008171 WO2007020103A2 (fr) 2005-08-18 2006-08-18 Nouvelle utilisation de composes peptidiques pour traiter une douleur musculaire
US11/506,523 US20070197657A1 (en) 2005-08-18 2006-08-18 Method for treating non-inflammatory musculoskeletal pain
US11/506,578 US20070048372A1 (en) 2005-08-18 2006-08-18 Method for treating non-inflammatory osteoarthritic pain
US11/506,523 2006-08-18
US11/506,577 US20070042969A1 (en) 2004-03-26 2006-08-18 Combination therapy for pain in painful diabetic neuropathy
PCT/EP2007/005036 WO2007141018A1 (fr) 2006-06-08 2007-06-06 Combinaison thérapeutique pour états médicaux douloureux

Publications (1)

Publication Number Publication Date
AU2007256352A1 true AU2007256352A1 (en) 2007-12-13

Family

ID=46964866

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2007256352A Abandoned AU2007256352A1 (en) 2006-06-08 2007-06-06 Therapeutic combination for painful medical conditions

Country Status (11)

Country Link
JP (1) JP2009539792A (fr)
KR (1) KR20090018863A (fr)
AR (1) AR061250A1 (fr)
AT (1) ATE530175T1 (fr)
AU (1) AU2007256352A1 (fr)
BR (1) BRPI0712494A2 (fr)
CA (1) CA2652667A1 (fr)
EA (1) EA200802412A1 (fr)
MX (1) MX2008015341A (fr)
TW (1) TW200814988A (fr)
WO (1) WO2007141018A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200846002A (en) * 2007-03-15 2008-12-01 Astellas Pharma Inc Novel prophylactic and/or therapeutic agent for diabetic neuropathy
TW200846003A (en) * 2007-03-15 2008-12-01 Astellas Pharma Inc Novel prophylactic and/or therapeutic agent for diabetic neuropathy
EP2116539A1 (fr) 2008-04-25 2009-11-11 Laboratorios Del. Dr. Esteve, S.A. 1-aryl-3-aminoalkoxy-pyrazoles en tant que ligands améliorant les effets analgésiques des opioïdes et réduisant leur dépendance
US20110152268A1 (en) * 2008-09-11 2011-06-23 Astellas Pharma Inc. Novel pharmaceutical composition for treating nociceptive pain
US8198268B2 (en) 2008-10-31 2012-06-12 Janssen Biotech, Inc. Tianeptine sulfate salt forms and methods of making and using the same
EP2353598A1 (fr) 2010-02-04 2011-08-10 Laboratorios Del. Dr. Esteve, S.A. Ligands sigma pour utilisation dans la prévention et/ou le traitement de la douleur post-opératoire
EP2353591A1 (fr) 2010-02-04 2011-08-10 Laboratorios Del. Dr. Esteve, S.A. Ligands sigma pour la potentialisation de l'effet analgésique d'opioïdes et d'opiacés dans la douleur post-opératoire et en atténuant la dépendance
EP2388005A1 (fr) 2010-05-21 2011-11-23 Laboratorios Del. Dr. Esteve, S.A. Ligands sigma pour la prévention et/ou le traitement du vomissement induit par la chimiothérapie ou la radiothérapie
SI2582366T1 (sl) 2010-06-15 2016-02-29 Gruenenthal Gmbh Farmacevtska kombinacija za zdravljenje bolečine
EP2415471A1 (fr) 2010-08-03 2012-02-08 Laboratorios Del. Dr. Esteve, S.A. Utilisation de ligands sigma dans l'hyperalgie induite par opioïdes
EP2524694A1 (fr) 2011-05-19 2012-11-21 Laboratorios Del. Dr. Esteve, S.A. Utilisation de ligands sigma dans la douleur liée au diabète de type 2
US9662305B2 (en) 2012-11-20 2017-05-30 Revive Therapeutics Inc. Use of bucillamine in the treatment of gout
JP2015537009A (ja) * 2012-11-20 2015-12-24 リバイブ・セラピューティクス・インコーポレイテッド 痛風の治療におけるブシラミンの使用
BR112016013754A2 (pt) 2013-12-17 2017-08-08 Esteve Labor Dr Recaptação de serotonina-norepinefrina inibidores (irsns) e combinações dos ligantes do receptor sigma
CN114306346A (zh) * 2021-12-14 2022-04-12 四川大学华西医院 拉莫三嗪在治疗系统性红斑狼疮中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60120104T2 (de) * 2001-03-20 2006-09-21 Schwarz Pharma Ag Neue Verwendung von Peptidverbindungen bei der Behandlung von nicht-neuropathischem Entzündungsschmerz
KR20060111524A (ko) * 2003-12-02 2006-10-27 쉬바르츠파르마에이지 펩타이드 화합물들의 중추 신경병증성 통증 치료를 위한신규한 용도
EP1579858A1 (fr) * 2004-03-26 2005-09-28 Schwarz Pharma Ag Nouvelle utilisation de peptides pour le traitement de la neuropathie diabètique
CN1950101B (zh) * 2004-04-16 2011-03-30 舒沃茨药物股份公司 肽化合物用于预防和治疗慢性头痛的用途
RU2006139930A (ru) * 2004-05-03 2008-06-10 Дюк Юниверсити (Сша/Сша) (Us) Составы для содействия снижению веса

Also Published As

Publication number Publication date
AR061250A1 (es) 2008-08-13
JP2009539792A (ja) 2009-11-19
ATE530175T1 (de) 2011-11-15
TW200814988A (en) 2008-04-01
WO2007141018A1 (fr) 2007-12-13
EA200802412A1 (ru) 2009-06-30
MX2008015341A (es) 2009-02-10
CA2652667A1 (fr) 2007-12-13
BRPI0712494A2 (pt) 2012-10-09
KR20090018863A (ko) 2009-02-23

Similar Documents

Publication Publication Date Title
US20120225119A1 (en) Therapeutic combination for painful medical conditions
US20070048372A1 (en) Method for treating non-inflammatory osteoarthritic pain
AU2007256352A1 (en) Therapeutic combination for painful medical conditions
US20070197657A1 (en) Method for treating non-inflammatory musculoskeletal pain
US20070042969A1 (en) Combination therapy for pain in painful diabetic neuropathy
US20100256179A1 (en) Combination therapy for pain in painful diabetic neuropathy
JP4977297B2 (ja) トラマドール物質及び抗痙攣薬を含んで成る組成物
JP5795145B2 (ja) 難治性てんかん重積症の治療用ペプチド化合物
AU2002333374A1 (en) Pharmaceutical composition comprising gabapentin or an analogue thereof and an (alpha)- aminoamide and its analgesic use
EP1423168A2 (fr) Composition pharmaceutique comprenant de la gabapentine ou un analogue de celle-ci et un $g(a)-aminoamide, et utilisation analgesique de ladite composition
CN101484152A (zh) 用于疼痛性医学病症的治疗组合
EP2026788B1 (fr) Combinaison thérapeutique pour états médicaux douloureux
BR112013000164B1 (pt) Agente terapêutico ou agente profilático
KR20080038408A (ko) 근육통 치료를 위한 펩티드 화합물의 신규한 용도
JP2010518147A (ja) 有機化合物の使用

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application